Introduction: The role of endovascular thrombectomy (EVT) for acute extra-large ischemic stroke patients with large vessel occlusion (LVO) is uncertain. We aimed to explore the clinical and safety outcomes of medical management (MM) plus EVT (EVT group) versus MM alone (MM group) among acute extra-large ischemic stroke patients with LVO within 24 h of last known well. Methods: XL STROKE (EVT for extra-large ischemic stroke) is an investigator-initiated, nationwide, prospective registry with blinded end point assessment performed at approximately 60 sites in China and will enroll up to 990 acute ischemic stroke patients within 24 h of last known well. Imaging inclusion criteria are occlusion of the internal carotid artery or the middle cerebral artery M1 or M2 segments, and Alberta Stroke Program Early Computed Tomography Score of 0 to 2 or an ischemic core volume ≥85 mL. All patients will be dichotomized into EVT group and MM group according to whether they received EVT or not. The primary outcome is the level of disability on the modified Rankin Scale at 90 ± 14 days. Safety outcomes include symptomatic intracranial hemorrhage within 48 h and mortality at 90 ± 14 days. Conclusion: Results from XL STROKE registry will provide constructive evidence of improved disability outcomes and safety with EVT for acute extra-large ischemic stroke patients with LVO within 24 h of last known well.

Journal Section:
Protocols
Keywords:
Acute ischemic stroke, Large vessel occlusion, Endovascular thrombectomy, Protocol
1.
Powers
WJ
,
Rabinstein
AA
,
Ackerson
T
,
Adeoye
OM
,
Bambakidis
NC
,
Becker
K
, et al.
Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association
.
Stroke
.
2019
;
50
(
12
):
e344
–
418
.
Google Scholar
PubMed
 
2.
Goyal
M
,
Menon
BK
,
van Zwam
WH
,
Dippel
DW
,
Mitchell
PJ
,
Demchuk
AM
, et al.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
.
Lancet
.
2016
;
387
(
10029
):
1723
–
31
.
Google Scholar
PubMed
 
3.
Turc
G
,
Bhogal
P
,
Fischer
U
,
Khatri
P
,
Lobotesis
K
,
Mazighi
M
, et al.
European stroke organisation (ESO): European society for minimally invasive neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke
.
J Neurointerv Surg
.
2023
;
15
(
8
):
e8
.
Google Scholar
PubMed
 
4.
Huo
X
,
Ma
G
,
Tong
X
,
Zhang
X
,
Pan
Y
,
Nguyen
TN
, et al.
Trial of endovascular Therapy for acute ischemic stroke with large infarct
.
N Engl J Med
.
2023
;
388
(
14
):
1272
–
83
.
Google Scholar
PubMed
 
5.
Yoshimura
S
,
Sakai
N
,
Yamagami
H
,
Uchida
K
,
Beppu
M
,
Toyoda
K
, et al.
Endovascular Therapy for acute stroke with a large ischemic region
.
N Engl J Med
.
2022
;
386
(
14
):
1303
–
13
.
Google Scholar
PubMed
 
6.
Sarraj
A
,
Hassan
AE
,
Abraham
MG
,
Ortega-Gutierrez
S
,
Kasner
SE
,
Hussain
MS
, et al.
Trial of endovascular thrombectomy for large ischemic strokes
.
N Engl J Med
.
2023
;
388
(
14
):
1259
–
71
.
Google Scholar
PubMed
 
7.
Costalat
V
,
Jovin
TG
,
Albucher
JF
,
Cognard
C
,
Henon
H
,
Nouri
N
, et al.
Trial of thrombectomy for stroke with a large infarct of unrestricted size
.
N Engl J Med
.
2024
;
390
(
18
):
1677
–
89
.
Google Scholar
PubMed
 
8.
Bendszus
M
,
Fiehler
J
,
Subtil
F
,
Bonekamp
S
,
Aamodt
AH
,
Fuentes
B
, et al.
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
.
Lancet
.
2023
;
402
(
10414
):
1753
–
63
.
Google Scholar
PubMed
 
9.
Xie
D
,
Huang
J
,
Fan
S
,
Guo
C
,
Sun
W
,
Peng
Z
, et al.
Endovascular Therapy and outcomes among patients with very large ischemic core stroke
.
JAMA Netw Open
.
2024
;
7
(
5
):
e249298
.
Google Scholar
PubMed
 
10.
Winkelmeier
L
,
Maros
M
,
Flottmann
F
,
Heitkamp
C
,
Schon
G
,
Thomalla
G
, et al.
Endovascular thrombectomy for large ischemic strokes with ASPECTS 0-2: a meta-analysis of randomized controlled trials
.
Clin Neuroradiol
.
2024
;
34
(
3
):
713
–
8
.
Google Scholar
PubMed
 
11.
Liu
L
,
Li
Z
,
Zhou
H
,
Duan
W
,
Huo
X
,
Xu
W
, et al.
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
.
Stroke Vasc Neurol
.
2023
;
8
(
6
):
e3
.
Google Scholar
PubMed
 
12.
Liu
L
,
Chen
W
,
Zhou
H
,
Duan
W
,
Li
S
,
Huo
X
, et al.
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
.
Stroke Vasc Neurol
.
2020
;
5
(
2
):
159
–
76
.
Google Scholar
PubMed
 
13.
von Kummer
R
,
Broderick
JP
,
Campbell
BC
,
Demchuk
A
,
Goyal
M
,
Hill
MD
, et al.
The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion Therapy
.
Stroke
.
2015
;
46
(
10
):
2981
–
6
.
Google Scholar
PubMed
 
14.
Nogueira
RG
,
Jadhav
AP
,
Haussen
DC
,
Bonafe
A
,
Budzik
RF
,
Bhuva
P
, et al.
Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct
.
N Engl J Med
.
2018
;
378
(
1
):
11
–
21
.
Google Scholar
PubMed
 
15.
Albers
GW
,
Marks
MP
,
Kemp
S
,
Christensen
S
,
Tsai
JP
,
Ortega-Gutierrez
S
, et al.
Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging
.
N Engl J Med
.
2018
;
378
(
8
):
708
–
18
.
Google Scholar
PubMed
 
16.
Sarraj
A
,
Hassan
AE
,
Abraham
MG
,
Ortega-Gutierrez
S
,
Kasner
SE
,
Hussain
MS
, et al.
Endovascular thrombectomy for large ischemic stroke across ischemic injury and penumbra profiles
.
JAMA
.
2024
;
331
(
9
):
750
–
63
.
Google Scholar
PubMed
 
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.